We are live on ! Find out more
GCL

Glazer Capital LLC Portfolio holdings

AUM $4.71B
1-Year Est. Return 81.93%
This Fund
S&P 500
This Quarter Est. Return
+4.3%
1 Year Est. Return
+81.93%
3 Year Est. Return
+319.13%
5 Year Est. Return
+526.52%
10 Year Est. Return
+4,797.43%
AUM
$3.86B
AUM Growth
-$1.59B
Cap. Flow
-$1.68B
Cap. Flow %
-43.43%
Top 10 Hldgs %
19.14%
Holding
821
New
112
Increased
267
Reduced
93
Closed
295
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUAC
301
DELISTED
ShoulderUp Technology Acquisition Corp.
SUAC
$642K 0.02%
63,025
+6,692
+12% +$67.4K
TGAAU
302
DELISTED
Target Global Acquisition I Corp. Unit
TGAAU
$630K 0.02%
61,371
+2,082
+4% +$21.1K
ZLSWU
303
DELISTED
Zalatoris II Acquisition Corp Unit
ZLSWU
$629K 0.02%
62,750
+61,879
+7,104% +$612K
FRSG
304
DELISTED
First Reserve Sustainable Growth Corp. Class A Common Stock
FRSG
$621K 0.02%
61,831
NETC
305
DELISTED
Nabors Energy Transition Corp.
NETC
$619K 0.02%
60,309
+11,299
+23% +$115K
KVSC
306
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
$608K 0.02%
61,030
-307,265
-83% -$3.04M
DPCS
307
DELISTED
DP Cap Acquisition Corp I Class A Ordinary Shares
DPCS
$607K 0.02%
59,157
+3,688
+7% +$37.5K
VPCBU
308
DELISTED
VPC Impact Acquisition Holdings II Unit
VPCBU
$601K 0.02%
59,574
GEEX
309
DELISTED
Games & Esports Experience Acquisition Corp. Class A Ordinary Shares
GEEX
$593K 0.02%
57,610
+33,724
+141% +$344K
PUCK
310
DELISTED
Goal Acquisitions Corp. Common Stock
PUCK
$587K 0.02%
58,339
-909,996
-94% -$9.05M
TRAQ
311
DELISTED
Trine II Acquisition Corp.
TRAQ
$587K 0.02%
+57,009
New +$578K
FCAX.U
312
DELISTED
Fortress Capital Acquisition Corp. Units, each consisting of one Class A ordinary share and one-fifth of one Warrant
FCAX.U
$536K 0.01%
54,127
+3,861
+8% +$38.7K
DEVS
313
DELISTED
DevvStream Corp
DEVS
$514K 0.01%
5,052
+3,986
+374% +$402K
IXAQU
314
DELISTED
IX Acquisition Corp. Unit
IXAQU
$513K 0.01%
+50,713
New +$510K
FMIV
315
DELISTED
Forum Merger IV Corporation Class A Common stock
FMIV
$510K 0.01%
50,836
-18,238
-26% -$181K
QOMO
316
DELISTED
Qomolangma Acquisition Corp. Common Stock
QOMO
$500K 0.01%
+49,900
New +$499K
KRNLU
317
DELISTED
Kernel Group Holdings, Inc. Units
KRNLU
$498K 0.01%
49,468
+41,415
+514% +$414K
MPRA
318
DELISTED
Mercato Partners Acquisition Corporation Class A Common Stock
MPRA
$483K 0.01%
47,302
+297
+0.6% +$3K
SOAR icon
319
Volato Group
SOAR
$7.24M
$476K 0.01%
1,873
+507
+37% +$127K
IGTA
320
DELISTED
Inception Growth Acquisition Limited Common Stock
IGTA
$470K 0.01%
46,387
+2,684
+6% +$26.9K
FRBN
321
DELISTED
Forbion European Acquisition Corp. Class A Ordinary Shares
FRBN
$466K 0.01%
45,131
+26,970
+149% +$275K
PNST
322
DELISTED
Pinstripes Holdings, Inc.
PNST
$463K 0.01%
45,320
+7,133
+19% +$72K
JUGG
323
DELISTED
Jaws Juggernaut Acquisition Corporation Class A Ordinary Share
JUGG
$457K 0.01%
45,397
-9,973
-18% -$99.3K
ZPTA
324
DELISTED
Zapata Computing Holdings Inc. Common Stock
ZPTA
$450K 0.01%
43,600
AEAE
325
DELISTED
AltEnergy Acquisition Corp
AEAE
$448K 0.01%
43,991
-2,899
-6% -$29.2K

Similar funds

Glazer Capital LLC's Q4 2022 Portfolio in Review

As of Q4 2022, Glazer Capital LLC held 821 positions worth $3.86B, down 29% from $5.46B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Glazer Capital LLC withdrew a net $1.68B in Q4 2022, closing 295 positions and reducing 93 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $187M position sold in full.

By sector, the portfolio is most concentrated in Financials at 69% of assets, up from 64% a quarter earlier, followed by Technology and Industrials.

Against the trend, Glazer Capital LLC opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $41M.

  • Glazer Capital LLC's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 360,496 shares worth $41M.
  • Glazer Capital LLC added most to Jaws Mustang Acquisition Corp. in Q4 2022, an estimated $52.5M increase.
  • Glazer Capital LLC's biggest Q4 2022 reduction was Envoy Medical, cutting an estimated $34M.
  • Glazer Capital LLC fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $187M.
  • Glazer Capital LLC's ten largest holdings make up 19% of its $3.86B portfolio in Q4 2022.
  • Glazer Capital LLC opened 112 new positions and closed 295 in Q4 2022.
  • Glazer Capital LLC's portfolio value fell 29% quarter-over-quarter to $3.86B.

Based on Glazer Capital LLC's 13F filing for Q4 2022, filed 14 Feb 2023.